AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21073734 — intervention group
Group type: COMPARATOR
Intervention: Plaster immobilization (in 90 degrees flexion, neutral position for pro-supination for a period of three weeks)
Number of subjects: 100
Study 21073734 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional treatment
Number of subjects: 100
Study 21073734 — intervention group
Group type: COMPARATOR
Intervention: Plaster immobilization
Number of subjects: 100
Study 18250349 — intervention group
Group type: COMPARATOR
Intervention: Doxorubicin plus cyclophosphamide followed by weekly paclitaxel (arm A)
Number of subjects: 2992
Study 18250349 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel then trastuzumab (arm B)
Number of subjects: 2992
Study 18250349 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel plus trastuzumab then trastuzumab alone (arm C)
Number of subjects: 2992
Study 16913243 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone iodine
Number of subjects: 22
Study 16913243 — intervention group
Group type: COMPARATOR
Intervention: Phosphate buffered saline (control)
Number of subjects: 22
Study 15071257 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluindione (anticoagulant) and aspirin (100 mg)
Number of subjects: 0
Study 15071257 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10878627 — intervention group
Group type: EXPERIMENTAL
Intervention: BeStent small
Number of subjects: 96
Study 10878627 — intervention group
Group type: EXPERIMENTAL
Intervention: NIR‐7
Number of subjects: 96
Study 8770380 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback training of voluntary control of respiratory resistance
Number of subjects: 0
Study 8770380 — intervention group
Group type: COMPARATOR
Intervention: Externally added flow resistive loads
Number of subjects: 0
Study 8770380 — intervention group
Group type: COMPARATOR
Intervention: Bronchoconstriction provoked by allergic agents
Number of subjects: 0
Study 1308247 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg/kg Triclofos elixir (Regimen I)
Number of subjects: 26
Study 1308247 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg Trichlofos elixir combined with 1 mg/kg promethazine elixir (Regimen II)
Number of subjects: 26
Study 6363930 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg) administered orally on a weekly basis and at the completion of training
Number of subjects: 940
Study 6363930 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered orally on a weekly basis and at the completion of training
Number of subjects: 940
Study 29500585 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam 10 mg (OXA10)
Number of subjects: 23
Study 29500585 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg (DIA10)
Number of subjects: 23
Study 29500585 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxazepam 30 mg (OXA30)
Number of subjects: 23
Study 29500585 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive tests (various)
Number of subjects: 23
Study 29500585 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive tests (ANT, DAT, PVT)
Number of subjects: 23
Study 27930706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Aerobic Exercise (AAE) at low intensity (45-50% max heart rate) for 35 minutes
Number of subjects: 121
Study 27930706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Aerobic Exercise (AAE) at moderate intensity (65-70% max heart rate) for 35 minutes
Number of subjects: 121
Study 27930706 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute Aerobic Exercise (AAE) at high intensity (85-90% max heart rate) for 35 minutes
Number of subjects: 121
Study 27930706 — intervention group
Group type: COMPARATOR
Intervention: Self-Myofascial Release Training (control group) for 35 minutes
Number of subjects: 121
Study 24962230 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone screening tool for SD/tremor
Number of subjects: 39
Study 22584959 — intervention group
Group type: EXPERIMENTAL
Intervention: Windbreaker jacket and pants
Number of subjects: 9
Study 22584959 — intervention group
Group type: COMPARATOR
Intervention: No additional clothing (control group)
Number of subjects: 9
Study 20492296 — intervention group
Group type: EXPERIMENTAL
Intervention: Heme-iron concentrate (HIC)
Number of subjects: 112
Study 20492296 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron sulfate (IS)
Number of subjects: 112
Study 20492296 — intervention group
Group type: COMPARATOR
Intervention: Placebo control (PC)
Number of subjects: 112
Study 17663610 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Enhancement Therapy (MET)
Number of subjects: 461
Study 17663610 — intervention group
Group type: COMPARATOR
Intervention: Counseling as Usual (CAU)
Number of subjects: 461
Study 16194202 — intervention group
Group type: EXPERIMENTAL
Intervention: Ximelagatran (24-60 mg b.i.d)
Number of subjects: 518
Study 16194202 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 518
Study 11807406 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene therapy for X‐linked severe combined immunodeficiency (SCID‐X1)
Number of subjects: 0
Study 10725989 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (control)
Number of subjects: 41
Study 7491887 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium‐ and sulfate‐rich mineral water (CS‐W) containing 11.2 mmol Ca/L (467 mg/L)
Number of subjects: 9
Study 7491887 — intervention group
Group type: COMPARATOR
Intervention: Milk
Number of subjects: 9
Study 7491887 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium‐ and sulfate‐rich mineral water (CS‐W)
Number of subjects: 9
Study 7491887 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium‐and sulfate‐rich mineral water (CS‐W)
Number of subjects: 9
Study 1686339 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of tetrazepam and a nonsteroid analgetic
Number of subjects: 60
Study 1686339 — intervention group
Group type: COMPARATOR
Intervention: Nonsteroid analgetic
Number of subjects: 60
Study 7019641 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline sulphate 0.5 mg via metered aerosol
Number of subjects: 12
Study 7019641 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally administered theophylline 5 mg/kg
Number of subjects: 12
Study 7019641 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of terbutaline and theophylline
Number of subjects: 12
Study 7019641 — intervention group
Group type: COMPARATOR
Intervention: Metered aerosol alone
Number of subjects: 12
Study 30889034 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic administration via REDCap or PelvicTrack App
Number of subjects: 234
Study 30889034 — intervention group
Group type: COMPARATOR
Intervention: Paper administration
Number of subjects: 234
Study 31494376 — intervention group
Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 109
Study 31494376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study 28659278 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathologists' interpretations of melanocytic skin lesions
Number of subjects: 240
Study 28659278 — intervention group
Group type: COMPARATOR
Intervention: Consensus diagnosis of experienced pathologists
Number of subjects: 240
Study 26347428 — intervention group
Group type: EXPERIMENTAL
Intervention: Language for Learning intervention (18 1-hour home-based therapy sessions)
Number of subjects: 200
Study 26347428 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 200
Study 26347428 — intervention group
Group type: EXPERIMENTAL
Intervention: Language for Learning intervention
Number of subjects: 200
Study 23472619 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-mg memantine
Number of subjects: 369
Study 23472619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 369
Study 20824769 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 422
Study 20824769 — intervention group
Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 422
Study 19631774 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol 1000 IU/day
Number of subjects: 95
Study 19631774 — intervention group
Group type: COMPARATOR
Intervention: Ergocalciferol 1000 IU/day
Number of subjects: 95
Study 17374671 — intervention group
Group type: EXPERIMENTAL
Intervention: Sprinkles‐WSB (S‐WSB)
Number of subjects: 415
Study 17374671 — intervention group
Group type: COMPARATOR
Intervention: WSB only (WSB)
Number of subjects: 415
Study 15314861 — intervention group
Group type: EXPERIMENTAL
Intervention: Epitalamin (bioregulator of the cytomedine class)
Number of subjects: 0
Study 11343009 — intervention group
Group type: EXPERIMENTAL
Intervention: Reusing suction catheters for a 24-hour period (n = 241)
Number of subjects: 486
Study 11343009 — intervention group
Group type: COMPARATOR
Intervention: Using a new catheter for each episode of suctioning (n = 245)
Number of subjects: 486
Study 11343009 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost analysis of reusing suction catheters
Number of subjects: 486
Study 9750805 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial plexus block using a peripheral nerve stimulator (group St)
Number of subjects: 111
Study 9750805 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial brachial plexus blockade with injection of 2/3 of the anaesthetic in back of and 1/3 in front of the artery (group TAP)
Number of subjects: 111
Study 9750805 — intervention group
Group type: EXPERIMENTAL
Intervention: Transarterial brachial plexus blockade with one single injection in back of the artery (group TP)
Number of subjects: 111
Study 9750805 — intervention group
Group type: COMPARATOR
Intervention: Nerve stimulator (group St)
Number of subjects: 111
Study 7941992 — intervention group
Group type: EXPERIMENTAL
Intervention: Endocrine treatment (medroxy-progesterone acetate 30 mg weekly and Tamoxifen 300 mg weekly)
Number of subjects: 43
Study 7941992 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation treatment (external beam photon treatment of the whole pelvis, average total dose of 3680 cGy rad)
Number of subjects: 43
Study 7941992 — intervention group
Group type: COMPARATOR
Intervention: Control group (no adjuvant treatment)
Number of subjects: 43
Study 3295547 — intervention group
Group type: EXPERIMENTAL
Intervention: Multipolar electrocoagulation
Number of subjects: 44
Study 3295547 — intervention group
Group type: COMPARATOR
Intervention: Sham multipolar electrocoagulation
Number of subjects: 44
Study 31578771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tadalafil 5 mg once daily for 6 weeks
Number of subjects: 26
Study 31578771 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 6 weeks
Number of subjects: 26
Study 30027292 — intervention group
Group type: EXPERIMENTAL
Intervention: C‐509T allele in TGFB1
Number of subjects: 287
Study 30027292 — intervention group
Group type: COMPARATOR
Intervention: No C‐509T allele in TGFB1
Number of subjects: 287
Study 27084290 — intervention group
Group type: EXPERIMENTAL
Intervention: Suspend before low feature of the Medtronic MiniMed 640G pump
Number of subjects: 0
Study 27084290 — intervention group
Group type: COMPARATOR
Intervention: SAPT alone (Control)
Number of subjects: 0
Study 25669435 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd-YAG laser
Number of subjects: 40
Study 25669435 — intervention group
Group type: COMPARATOR
Intervention: Topical terbinafine
Number of subjects: 40
Study 24135775 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir
Number of subjects: 117
Study 24135775 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz
Number of subjects: 117
Study 24135775 — intervention group
Group type: COMPARATOR
Intervention: control group (not specified)
Number of subjects: 117
Study 21909316 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher temperatures
Number of subjects: 12836
Study 21909316 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat humidity index
Number of subjects: 12836
Study 21909316 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher temperatures during specific months (June-September in Sylhet; April-September in Mirzapur)
Number of subjects: 12836
Study 19066253 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive warm-up programme
Number of subjects: 1892
Study 19066253 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 1892
Study 16564210 — intervention group
Group type: EXPERIMENTAL
Intervention: Extra early support measures
Number of subjects: 72
Study 16564210 — intervention group
Group type: COMPARATOR
Intervention: Standard follow-up
Number of subjects: 72
Study 12569235 — intervention group
Group type: EXPERIMENTAL
Intervention: High intervention (n = 74)
Number of subjects: 212
Study 12569235 — intervention group
Group type: EXPERIMENTAL
Intervention: Low intervention (n = 69)
Number of subjects: 212
Study 12569235 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 69)
Number of subjects: 212
Study 12569235 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (High, Low, Control)
Number of subjects: 212
Study 11682403 — intervention group
Group type: COMPARATOR
Intervention: Remifentanil 10 microg
Number of subjects: 120
Study 11682403 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 10 microg plus propofol 5 mg
Number of subjects: 120
Study 9322450 — intervention group
Group type: EXPERIMENTAL
Intervention: Dichloroacetate (DCA) 80 mg/kg intravenously in divided doses
Number of subjects: 80
Study 9322450 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DCA)
Number of subjects: 80
Study 7933639 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet (n = 21) composed of amino acid based with low fat content
Number of subjects: 40
Study 7933639 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-elemental diet (n = 19) which is oligopeptide-based and has higher fat content
Number of subjects: 40
Study 3361096 — intervention group
Group type: EXPERIMENTAL
Intervention: Training group that received formal instructions in principles underlying figural relations problem solution (n = 24)
Number of subjects: 69
Study 3361096 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-instructed interactive group that received practice with figural relations training materials but no formal instruction (n = 21)
Number of subjects: 69
Study 3361096 — intervention group
Group type: COMPARATOR
Intervention: No-contact control group (n = 24)
Number of subjects: 69
Study 30928180 — intervention group
Group type: EXPERIMENTAL
Intervention: 40IU intranasal oxytocin
Number of subjects: 30
Study 30928180 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 28527771 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin plus Clopidogrel (DAPT)
Number of subjects: 222
Study 28527771 — intervention group
Group type: COMPARATOR
Intervention: Aspirin alone (SAPT)
Number of subjects: 222
Study 25872769 — intervention group
Group type: EXPERIMENTAL
Intervention: Short sleep condition (6.5 hr in bed)
Number of subjects: 10
Study 25872769 — intervention group
Group type: COMPARATOR
Intervention: Long sleep condition (10 hr in bed)
Number of subjects: 10
Study 24274128 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention administered through the primary health care system, focusing on hazard awareness and preparedness for earthquakes and floods.
Number of subjects: 9200
Study 24274128 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 9200
Study 21599901 — intervention group
Group type: EXPERIMENTAL
Intervention: DESPATCH intervention (specialist decisional support, written feedback, academic detailing sessions, practice resources, evidence-based information)
Number of subjects: 0
Study 21599901 — intervention group
Group type: COMPARATOR
Intervention: Evidence-based guidelines (control)
Number of subjects: 0
Study 19230772 — intervention group
Group type: EXPERIMENTAL
Intervention: Azacitidine (75 mg/m² per day for 7 days every 28 days)
Number of subjects: 358
Study 19230772 — intervention group
Group type: COMPARATOR
Intervention: Conventional care (best supportive care, low-dose cytarabine, or intensive chemotherapy)
Number of subjects: 358
Study 17029304 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg citalopram diluted in 250 ml 0.9% saline
Number of subjects: 0
Study 17029304 — intervention group
Group type: COMPARATOR
Intervention: 250 ml 0.9% saline (placebo)
Number of subjects: 0
Study 12524634 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 183
Study 12524634 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline
Number of subjects: 183
Study 12524634 — intervention group
Group type: COMPARATOR
Intervention: Control group (OPD)
Number of subjects: 183
Study 10947034 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (5 mg)
Number of subjects: 14
Study 10947034 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (0.1 mg)
Number of subjects: 14
Study 10947034 — intervention group
Group type: COMPARATOR
Intervention: Temazepam (20 mg)
Number of subjects: 14
Study 10947034 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (all doses)
Number of subjects: 14
Study 9102371 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative management (experimental group)
Number of subjects: 0
Study 9102371 — intervention group
Group type: COMPARATOR
Intervention: Interventionist management (control group)
Number of subjects: 0
Study 9102371 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 8448756 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard vincristine (V), dactinomycin (A), and cyclophosphamide (C)
Number of subjects: 999
Study 8448756 — intervention group
Group type: COMPARATOR
Intervention: Standard VA
Number of subjects: 999
Study 8448756 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive VA
Number of subjects: 999
Study 8448756 — intervention group
Group type: COMPARATOR
Intervention: Repetitive-pulse VAC
Number of subjects: 999
Study 8448756 — intervention group
Group type: COMPARATOR
Intervention: Repetitive-pulse VAdrC-VAC (Adr, Adriamycin [doxorubicin])
Number of subjects: 999
Study 8448756 — intervention group
Group type: EXPERIMENTAL
Intervention: Central nervous system prophylaxis for Group III patients with cranial parameningeal sarcoma
Number of subjects: 999
Study 8448756 — intervention group
Group type: EXPERIMENTAL
Intervention: Same regimens as Group III
Number of subjects: 999
Study 8448756 — intervention group
Group type: EXPERIMENTAL
Intervention: IRS‐II (including EA and all pelvic tumors)
Number of subjects: 999
Study 8448756 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonmetastatic patients in IRS‐II
Number of subjects: 999
Study 30938839 — intervention group
Group type: EXPERIMENTAL
Intervention: Minipool nucleic acid testing (MP-NAT) using pools of 6 (MP6)
Number of subjects: 0
Study 30938839 — intervention group
Group type: EXPERIMENTAL
Intervention: Minipool nucleic acid testing (MP-NAT) using pools of 16 (MP16)
Number of subjects: 0
Study 30938839 — intervention group
Group type: EXPERIMENTAL
Intervention: Minipool nucleic acid testing (MP-NAT)
Number of subjects: 0
Study 28077419 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocalciferol (50,000 units once a week for 8 weeks)
Number of subjects: 93
Study 28077419 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 25387601 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus chemotherapy (armA)
Number of subjects: 138
Study 25387601 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (armB)
Number of subjects: 138
Study 25387601 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients without liver surgery in armA
Number of subjects: 138
Study 25387601 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall analysis of ETS as a predictor
Number of subjects: 138
Study 23228201 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium 0.6‐1.2 mEq/L
Number of subjects: 742
Study 23228201 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium <0.6 mEq/L
Number of subjects: 742
Study 23228201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 742
Study 21292635 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression profiling
Number of subjects: 162
Study 21292635 — intervention group
Group type: EXPERIMENTAL
Intervention: 29-transcript predictive model
Number of subjects: 162
Study 21292635 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene expression profile data
Number of subjects: 162
Study 21292635 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional pathway analysis
Number of subjects: 162
Study 18245031 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT) internet intervention
Number of subjects: 525
Study 18245031 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression information website
Number of subjects: 525
Study 18245031 — intervention group
Group type: COMPARATOR
Intervention: Placebo control condition
Number of subjects: 525
Study 16155359 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vitamin E supplementation (600 mg/day)
Number of subjects: 31
Study 16155359 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E-coated dialyzer
Number of subjects: 31
Study 12882653 — intervention group
Group type: EXPERIMENTAL
Intervention: Protease inhibitor (PI) therapy
Number of subjects: 10986
Study 12882653 — intervention group
Group type: COMPARATOR
Intervention: NRTI-only therapy
Number of subjects: 10986
Study 10371242 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03 mg/kg triazolam (Halcion)
Number of subjects: 54
Study 10371242 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 54
Study 8977596 — intervention group
Group type: EXPERIMENTAL
Intervention: Single puffs via spacer (1200 micrograms)
Number of subjects: 10
Study 8977596 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple puffs via spacer (3 x 4 puffs)
Number of subjects: 10
Study 8977596 — intervention group
Group type: EXPERIMENTAL
Intervention: Single puffs with 20 second delay via spacer
Number of subjects: 10
Study 8977596 — intervention group
Group type: COMPARATOR
Intervention: Normal spacer (prewashed)
Number of subjects: 10
Study 8977596 — intervention group
Group type: COMPARATOR
Intervention: Antistatic treated spacer (prewashed)
Number of subjects: 10
Study 1675865 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate treatment (n = 76)
Number of subjects: 144
Study 1675865 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 68)
Number of subjects: 144
Study 6347278 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + cyclophosphamide (C) for 12 monthly cycles
Number of subjects: 805